Table 3.

Risk of deaths for patients with bladder cancer according gender and Cyproheptadine status

Risk factor	Regression coefficient	HR (95% CI)	p-Value
Noncyproheptadine VS Cyproheptadine
Noncyproheptadine	0	1
Cyproheptadine	-0.786	0.456 (0.214-0.970)	0.041*
Gender
Male	0	1
Female	-0.098	0.906 (0.685-1.199)	0.491

Cox regression. HR, Hazards Ratio.

^* P < 0.05.